These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2965128)

  • 1. Pharmacokinetics of 14C-teicoplanin in healthy volunteers.
    Buniva G; Del Favero A; Bernareggi A; Patoia L; Palumbo R
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():23-8. PubMed ID: 2965128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers.
    Thompson GA; Smithers JA; Kenny MT; Dulworth JK; Kulmala HK; Yuh L; Lewis EW; Antony KK
    Biopharm Drug Dispos; 1992 Apr; 13(3):213-20. PubMed ID: 1533542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function.
    Derbyshire N; Webb DB; Roberts D; Glew D; Williams JD
    J Antimicrob Chemother; 1989 Jun; 23(6):869-76. PubMed ID: 2527223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of teicoplanin in the elderly.
    Rosina R; Villa G; Danese A; Cavenaghi L; Picardi L; Salvadeo A
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():39-45. PubMed ID: 2965130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers.
    Smithers JA; Kulmala HK; Thompson GA; Antony KK; Lewis EW; Ruberg SJ; Kenny MT; Dulworth JK; Brackman MA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):115-20. PubMed ID: 1534211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses.
    Del Favero A; Patoia L; Rosina R; Buniva G; Danese A; Bernareggi A; Molini E; Cavenaghi L
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2551-7. PubMed ID: 1839759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of teicoplanin in pediatric patients.
    Terragna A; Ferrea G; Loy A; Danese A; Bernareggi A; Cavenaghi L; Rosina R
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1223-6. PubMed ID: 2973284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administration to humans.
    Antony KK; Lewis EW; Kenny MT; Dulworth JK; Brackman MB; Kuzma R; Yuh L; Eller MG; Thompson GA
    J Pharm Sci; 1991 Jun; 80(6):605-7. PubMed ID: 1834827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Clin Pharmacokinet; 2008; 47(12):793-805. PubMed ID: 19026035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of teicoplanin in varying degrees of renal function.
    Lam YW; Kapusnik-Uner JE; Sachdeva M; Hackbarth C; Gambertoglio JG; Sande MA
    Clin Pharmacol Ther; 1990 May; 47(5):655-61. PubMed ID: 2140543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
    Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
    Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin pharmacokinetics in patients with chronic renal failure.
    Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses.
    Outman WR; Nightingale CH; Sweeney KR; Quintiliani R
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2114-7. PubMed ID: 2149920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of individual components of teicoplanin in man.
    Bernareggi A; Danese A; Cometti A; Buniva G; Rowland M
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):525-43. PubMed ID: 2149149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and excretion of dalbavancin in the rat.
    Cavaleri M; Riva S; Valagussa A; Guanci M; Colombo L; Dowell J; Stogniew M
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii31-5. PubMed ID: 15750035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics and tissue penetration of teicoplanin.
    Novelli A; Mazzei T; Reali EF; Mini E; Periti P
    Int J Clin Pharmacol Res; 1989; 9(3):233-7. PubMed ID: 2526102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of teicoplanin.
    Rowland M
    Clin Pharmacokinet; 1990 Mar; 18(3):184-209. PubMed ID: 2138946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
    Bernareggi A; Borgonovi M; Del Favero A; Rosina R; Gavanaghi L
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():256-60. PubMed ID: 1840325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of teicoplanin.
    Ripa S; Ferrante L; Mignini F; Falcioni E
    Chemotherapy; 1988; 34(3):178-84. PubMed ID: 2970949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.